日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Recent Advances in Dual COX/LOX Inhibitor Design (2020-2024): Establishing "The Rule of Four for Inflammation"

双重COX/LOX抑制剂设计的最新进展(2020-2024):确立“炎症的四法则”

Chatzipieris, Filippos Panteleimon; Petsas, Errikos; Lambrinidis, George; Vassiliou, Stamatia; Chasapis, Christos T

Unlocking Novel Therapeutic Potential of Angiotensin II Receptor Blockers

释放血管紧张素II受体阻滞剂的新型治疗潜力

Chatzipieris, Filippos Panteleimon; Mavromoustakou, Kiriaki; Matsoukas, John M; Mavromoustakos, Thomas

Structure-Based Design and In Silico Evaluation of a Lipophilic Cyclooctanoyl- Derivative as a Renin Inhibitor: Lessons from Withdrawn Aliskiren

基于结构的亲脂性环辛酰衍生物的设计和计算机模拟评价:从撤市的阿利沙坦中汲取的教训

Pavlos, Dimitrios; Petsas, Errikos; Chatzipieris, Filippos Panteleimon; Mavromoustakos, Thomas; Chasapis, Christos T

Structural and Computational Insights into the Angiotensin II Type 1 Receptor: Advances in Antagonist Design and Implications for Hypertension Therapy (2020-2024)

血管紧张素II 1型受体的结构和计算见解:拮抗剂设计进展及其对高血压治疗的意义(2020-2024)

Chatzipieris, Filippos Panteleimon; Petsas, Errikos; Lambrinidis, George; Matsoukas, John M; Mavromoustakos, Thomas

New Prospects in the Inhibition of Monoamine Oxidase‑B (MAO-B) Utilizing Propargylamine Derivatives for the Treatment of Alzheimer's Disease: A Review

利用炔丙胺衍生物抑制单胺氧化酶-B (MAO-B) 治疗阿尔茨海默病的新前景:综述

Chatzipieris, Filippos Panteleimon; Kokkalis, Athanasios; Georgiou, Nikitas; Petsas, Errikos; Apostolou, Ektoras Vasileios; Vougioukalakis, Georgios C; Mavromoustakos, Thomas

Unraveling the Potential Pathogenic Role of Squalene Synthase (SQS) in Lung Cancer Using Enzyme Inhibitors as Molecular Tools

利用酶抑制剂作为分子工具揭示角鲨烯合酶(SQS)在肺癌中的潜在致病作用

Katavati, Theodora; Chatzipieris, Filippos P; Magkrioti, Christiana; Stylianaki, Elli-Anna; Aerakis, Emmanouil; Grammenoudi, Sofia; Tsoumakidou, Maria; Aidinis, Vassilis; Matralis, Alexios N; Kourounakis, Angeliki P